Search research articles
Contact Us
Filters
Showing results (1-10 of 47) with videos related to
Page
of 5
Sort By:
Cardiovascular & Hematological Disorders Drug Targets
|
January 23, 2010
A Review on the risk of myocardial infarction associated with the NSAID diclofenac
Florian Krötz, Lena Struthmann
Current Drug Targets
|
November 1, 2006
Cyclooxygenase inhibition and atherothrombosis
Hae-Young Sohn, Florian Krötz
Expert Opinion on Pharmacotherapy
|
October 27, 2004
Vascular restenosis - striving for therapy
Thomas M Schiele, Florian Krötz, Volker Klauss
Vascular Health and Risk Management
|
October 2, 2008
Antiplatelet drugs in cardiological practice: established strategies and new developments
Florian Krötz, Hae-Young Sohn, Volker Klauss
Arteriosclerosis, Thrombosis, and Vascular Biology
|
September 18, 2004
Reactive oxygen species: players in the platelet game
Florian Krötz, Hae-Young Sohn, Ulrich Pohl
Cellular Signalling
|
September 29, 2009
Suppression of DNA-PKcs enhances FGF-2 dependent human endothelial cell proliferation via negative regulation of Akt
Hanna Mannell, Ariane Hammitzsch, Ramona Mettler, et al.
Current Pharmaceutical Design
|
February 24, 2005
Intracoronary brachytherapy--clinical state and pathophysiological considerations
Florian Krötz, Hae-Young Sohn, Volker Klauss, et al.
Expert Opinion on Biological Therapy
|
July 26, 2003
Enhancing and targeting nucleic acid delivery by magnetic force
Christian Plank, Martina Anton, Carsten Rudolph, et al.
Journal of Vascular Research
|
October 8, 2003
Magnetofection potentiates gene delivery to cultured endothelial cells
Florian Krötz, Hae-Young Sohn, Torsten Gloe, et al.
Mini Reviews in Medicinal Chemistry
|
December 16, 2006
Prothrombotic potential of NSAID in ischemic heart disease
Florian Krötz, Nicole Hellwig, Thomas M Schiele, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 47) with videos related to
Sort By:
Page
of 5
Cardiovascular & Hematological Disorders Drug Targets
|
January 23, 2010
A Review on the risk of myocardial infarction associated with the NSAID diclofenac
Florian Krötz, Lena Struthmann
Current Drug Targets
|
November 1, 2006
Cyclooxygenase inhibition and atherothrombosis
Hae-Young Sohn, Florian Krötz
Expert Opinion on Pharmacotherapy
|
October 27, 2004
Vascular restenosis - striving for therapy
Thomas M Schiele, Florian Krötz, Volker Klauss
Vascular Health and Risk Management
|
October 2, 2008
Antiplatelet drugs in cardiological practice: established strategies and new developments
Florian Krötz, Hae-Young Sohn, Volker Klauss
Arteriosclerosis, Thrombosis, and Vascular Biology
|
September 18, 2004
Reactive oxygen species: players in the platelet game
Florian Krötz, Hae-Young Sohn, Ulrich Pohl
Cellular Signalling
|
September 29, 2009
Suppression of DNA-PKcs enhances FGF-2 dependent human endothelial cell proliferation via negative regulation of Akt
Hanna Mannell, Ariane Hammitzsch, Ramona Mettler, et al.
Current Pharmaceutical Design
|
February 24, 2005
Intracoronary brachytherapy--clinical state and pathophysiological considerations
Florian Krötz, Hae-Young Sohn, Volker Klauss, et al.
Expert Opinion on Biological Therapy
|
July 26, 2003
Enhancing and targeting nucleic acid delivery by magnetic force
Christian Plank, Martina Anton, Carsten Rudolph, et al.
Journal of Vascular Research
|
October 8, 2003
Magnetofection potentiates gene delivery to cultured endothelial cells
Florian Krötz, Hae-Young Sohn, Torsten Gloe, et al.
Mini Reviews in Medicinal Chemistry
|
December 16, 2006
Prothrombotic potential of NSAID in ischemic heart disease
Florian Krötz, Nicole Hellwig, Thomas M Schiele, et al.
Page
of 5